ബ്രെയിൻ ട്യൂമർ (ഗ്ലിയോമ)

High grade gliomas, particularly glioblastoma, are among the most aggressive brain tumors and are associated with poor outcomes despite standard treatment. Many patients, especially older adults or those with poor general health, are not suitable for surgery and have a life expectancy of less than 12 months. Current standard includes a shortened course of radiotherapy (over 3 weeks) combined with chemotherapy using temozolomide (TMZ), which offers limited survival benefits. This study aims to explore whether delivering radiotherapy in a shorter duration (1 or 2 weeks) at a higher dose, guided …

സ്പോൺസർ: ടാറ്റാ മെമ്മോറിയൽ സെന്റർ
ClinicalTrials.gov-ൽ NCT07338539
രജിസ്ട്രിയിൽ അവസാനമായി അപ്ഡേറ്റ് ചെയ്തത് 18 May 2026 · ഞങ്ങൾ വായിച്ചത് 20 Oct 2026